SCHEMBL8264016

SCHEMBL8264016

CCC(=O)N1CCSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789686 0.86 EPHX2 (0.46)
SCHEMBL9946326 0.83 DPP4 (0.47)
SCHEMBL10611575 0.82 DPP4 (0.47)
SCHEMBL6052795 0.78
SCHEMBL4160072 0.78
SCHEMBL5069160 0.78
SCHEMBL9944489 0.78 DPP4 (0.43)
SCHEMBL24102652 0.77 L3MBTL1 (0.58)
SCHEMBL15158364 0.77 BLM (0.44)
Hydrochloric Acid SCHEMBL8552428 0.77 DPP7 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017162522-A1 HERBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2017-09-28 WO disclosed
US-8044198-B2 Sirtuin modulating compounds SIRTRIS PHARMACEUTICALS, INC. (US) 2011-10-25 US disclosed
WO-2011037793-A1 SUBSTITUTED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES MERCK SHARP & DOHME CORP. (US) 2011-03-31 WO disclosed
US-20090099170-A1 Sirtuin modulating compounds SIRTRIS PHARMACEUTICALS, INC. (US) 2009-04-16 US disclosed
WO-2007057128-A1 NOVEL DUAL PEPTIDASE INHIBITORS AS PRODRUGS FOR THE THERAPY OF INFLAMMATORY AND OTHER DISORDERS IMTM GMBH (DE) 2007-05-24 WO disclosed
WO-2006063113-A2 UREAS AS FACTOR XA INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2006-06-15 WO disclosed